John Mario Giurini, D.P.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 26 | 2024 | 380 | 2.430 |
Why?
|
| Foot Ulcer | 10 | 2023 | 63 | 1.580 |
Why?
|
| Tarsal Tunnel Syndrome | 2 | 2019 | 9 | 1.130 |
Why?
|
| Hallux | 3 | 2024 | 43 | 1.060 |
Why?
|
| Ganglion Cysts | 1 | 2019 | 28 | 0.660 |
Why?
|
| Tibial Nerve | 3 | 2019 | 50 | 0.620 |
Why?
|
| Diabetes Mellitus | 9 | 2023 | 5816 | 0.580 |
Why?
|
| Diabetic Neuropathies | 19 | 2012 | 405 | 0.540 |
Why?
|
| Wound Healing | 9 | 2024 | 2783 | 0.460 |
Why?
|
| Endocrinology | 3 | 2023 | 441 | 0.410 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2013 | 167 | 0.390 |
Why?
|
| Foot | 11 | 2009 | 573 | 0.370 |
Why?
|
| Osteomyelitis | 3 | 2024 | 407 | 0.350 |
Why?
|
| Arthropathy, Neurogenic | 7 | 2006 | 29 | 0.320 |
Why?
|
| Neurilemmoma | 1 | 2013 | 523 | 0.300 |
Why?
|
| Podiatry | 3 | 2022 | 28 | 0.260 |
Why?
|
| Calcaneus | 1 | 2007 | 142 | 0.260 |
Why?
|
| Foot Deformities | 1 | 2005 | 34 | 0.250 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 1152 | 0.240 |
Why?
|
| Ankle | 2 | 2019 | 349 | 0.220 |
Why?
|
| Ulcer | 1 | 2023 | 204 | 0.190 |
Why?
|
| Metatarsus | 6 | 1995 | 18 | 0.190 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 694 | 0.190 |
Why?
|
| Skin Ulcer | 3 | 1991 | 129 | 0.170 |
Why?
|
| Interleukin-10 | 1 | 2024 | 1174 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2007 | 1368 | 0.150 |
Why?
|
| Shoes | 3 | 1996 | 94 | 0.150 |
Why?
|
| Foot Diseases | 4 | 1993 | 147 | 0.150 |
Why?
|
| Debridement | 3 | 2018 | 492 | 0.140 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 442 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.140 |
Why?
|
| Orthotic Devices | 2 | 1996 | 129 | 0.140 |
Why?
|
| Diabetes Complications | 3 | 1993 | 1317 | 0.140 |
Why?
|
| Retinal Diseases | 1 | 2023 | 702 | 0.140 |
Why?
|
| Curettage | 1 | 2016 | 73 | 0.130 |
Why?
|
| Bandages | 2 | 1998 | 269 | 0.130 |
Why?
|
| Reference Standards | 3 | 2023 | 1003 | 0.120 |
Why?
|
| Standard of Care | 3 | 2023 | 550 | 0.120 |
Why?
|
| Bacteremia | 2 | 2018 | 980 | 0.120 |
Why?
|
| Reoperation | 2 | 2024 | 4282 | 0.120 |
Why?
|
| Foot Deformities, Acquired | 1 | 1994 | 27 | 0.120 |
Why?
|
| Metatarsophalangeal Joint | 3 | 2009 | 41 | 0.120 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 1406 | 0.110 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 209 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2007 | 6346 | 0.100 |
Why?
|
| Insulin | 1 | 2007 | 6578 | 0.100 |
Why?
|
| Metatarsal Bones | 1 | 1993 | 111 | 0.100 |
Why?
|
| Sesamoid Bones | 1 | 1991 | 13 | 0.100 |
Why?
|
| Middle Aged | 31 | 2024 | 219568 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2007 | 3432 | 0.090 |
Why?
|
| Microcirculation | 3 | 2007 | 1273 | 0.090 |
Why?
|
| Humans | 52 | 2024 | 758406 | 0.090 |
Why?
|
| Postoperative Complications | 4 | 2024 | 15637 | 0.080 |
Why?
|
| Gout | 1 | 2016 | 618 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 2009 | 4902 | 0.070 |
Why?
|
| Skin | 3 | 2012 | 4464 | 0.070 |
Why?
|
| Cholinesterases | 1 | 1986 | 32 | 0.070 |
Why?
|
| Succinylcholine | 1 | 1986 | 66 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 198 | 0.070 |
Why?
|
| Societies, Medical | 3 | 2023 | 3891 | 0.070 |
Why?
|
| Joints | 3 | 2016 | 321 | 0.070 |
Why?
|
| Male | 29 | 2024 | 358747 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 12075 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2009 | 310 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 39059 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2024 | 80168 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 488 | 0.060 |
Why?
|
| Aged | 21 | 2024 | 168218 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7403 | 0.060 |
Why?
|
| Chemokine CX3CL1 | 1 | 2024 | 64 | 0.060 |
Why?
|
| Foot Bones | 1 | 2003 | 23 | 0.060 |
Why?
|
| Foot Joints | 1 | 2003 | 35 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2024 | 269 | 0.050 |
Why?
|
| Female | 28 | 2024 | 390323 | 0.050 |
Why?
|
| Forefoot, Human | 1 | 2002 | 31 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2005 | 1470 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2024 | 372 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2024 | 696 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 36284 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2024 | 1130 | 0.040 |
Why?
|
| Atrophy | 1 | 2005 | 1627 | 0.040 |
Why?
|
| Adult | 20 | 2024 | 219935 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 64378 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2007 | 1028 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2007 | 1607 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2024 | 1173 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 1526 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 1986 | 915 | 0.040 |
Why?
|
| Risk Factors | 10 | 2016 | 73809 | 0.040 |
Why?
|
| Diabetic Angiopathies | 2 | 2007 | 802 | 0.030 |
Why?
|
| Bone Diseases, Infectious | 1 | 2016 | 16 | 0.030 |
Why?
|
| Alginates | 1 | 1998 | 248 | 0.030 |
Why?
|
| Ischemia | 2 | 1996 | 1863 | 0.030 |
Why?
|
| Reference Values | 4 | 2009 | 4919 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5797 | 0.030 |
Why?
|
| Brachial Artery | 1 | 1997 | 365 | 0.030 |
Why?
|
| Leg Ulcer | 1 | 1996 | 70 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2005 | 1263 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2024 | 3156 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 1911 | 0.030 |
Why?
|
| Pressure | 4 | 2002 | 1155 | 0.030 |
Why?
|
| Toe Joint | 1 | 1994 | 19 | 0.030 |
Why?
|
| Postoperative Care | 3 | 1991 | 1471 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 3069 | 0.030 |
Why?
|
| Gout Suppressants | 1 | 2016 | 177 | 0.030 |
Why?
|
| Oxygen | 1 | 2005 | 4191 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 1995 | 377 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 318 | 0.030 |
Why?
|
| Abscess | 1 | 2016 | 605 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 167 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2009 | 2868 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1995 | 498 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 4342 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1996 | 475 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 95 | 0.030 |
Why?
|
| Arthroplasty | 1 | 1994 | 313 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15785 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 4429 | 0.020 |
Why?
|
| Tendons | 1 | 2016 | 552 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 15225 | 0.020 |
Why?
|
| Chronic Disease | 5 | 1997 | 9267 | 0.020 |
Why?
|
| Achilles Tendon | 1 | 1993 | 179 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12951 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 590 | 0.020 |
Why?
|
| Collagen | 1 | 1998 | 2635 | 0.020 |
Why?
|
| Decision Trees | 1 | 1991 | 504 | 0.020 |
Why?
|
| Cytokines | 1 | 2024 | 7338 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 632 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13468 | 0.020 |
Why?
|
| Prognosis | 3 | 2024 | 29557 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 2009 | 261 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2024 | 54137 | 0.020 |
Why?
|
| Fasciitis | 1 | 1989 | 67 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 961 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1268 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 1994 | 973 | 0.020 |
Why?
|
| Walking | 1 | 1994 | 1188 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 2009 | 253 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 1845 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8530 | 0.020 |
Why?
|
| Incidence | 2 | 2016 | 21272 | 0.020 |
Why?
|
| Critical Pathways | 2 | 2000 | 473 | 0.020 |
Why?
|
| Heart Rate | 1 | 1997 | 4166 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 771 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 266 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1991 | 1436 | 0.020 |
Why?
|
| Tritium | 1 | 2005 | 707 | 0.020 |
Why?
|
| Osteotomy | 1 | 1990 | 836 | 0.010 |
Why?
|
| Forearm | 1 | 2005 | 427 | 0.010 |
Why?
|
| Time Factors | 3 | 2018 | 39872 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6439 | 0.010 |
Why?
|
| Heel | 1 | 2002 | 37 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 41256 | 0.010 |
Why?
|
| Aged, 80 and over | 6 | 2000 | 58683 | 0.010 |
Why?
|
| Exercise | 1 | 1997 | 5788 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9599 | 0.010 |
Why?
|
| Recurrence | 2 | 1994 | 8426 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9304 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6954 | 0.010 |
Why?
|
| Vibration | 1 | 2000 | 327 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23884 | 0.010 |
Why?
|
| Hospitalization | 1 | 2016 | 10652 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3446 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2007 | 2880 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1998 | 588 | 0.010 |
Why?
|
| Metacarpus | 1 | 1995 | 36 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3526 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1997 | 914 | 0.010 |
Why?
|
| Perception | 1 | 2000 | 1197 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2005 | 22029 | 0.010 |
Why?
|
| Movement | 1 | 2000 | 1474 | 0.010 |
Why?
|
| Methods | 1 | 1993 | 1074 | 0.010 |
Why?
|
| Motor Activity | 1 | 2002 | 2685 | 0.010 |
Why?
|
| Physical Examination | 1 | 1997 | 1245 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1996 | 2850 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 10718 | 0.010 |
Why?
|
| Arteries | 1 | 1994 | 1125 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1997 | 1669 | 0.000 |
Why?
|
| Patient Care Team | 1 | 2000 | 2504 | 0.000 |
Why?
|
| Treatment Failure | 1 | 1994 | 2640 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1997 | 6354 | 0.000 |
Why?
|
| Muscles | 1 | 1993 | 1579 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1995 | 1825 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2005 | 12876 | 0.000 |
Why?
|
| Gait | 1 | 1993 | 812 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 20055 | 0.000 |
Why?
|
| Disabled Persons | 1 | 1996 | 1224 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13276 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14641 | 0.000 |
Why?
|
| Necrosis | 1 | 1989 | 1604 | 0.000 |
Why?
|
| Patient Selection | 1 | 1996 | 4244 | 0.000 |
Why?
|
| Adolescent | 2 | 1995 | 87892 | 0.000 |
Why?
|
| United States | 2 | 2000 | 72136 | 0.000 |
Why?
|
| Pain | 1 | 1995 | 5065 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1996 | 14490 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 167768 | 0.000 |
Why?
|